TransCode Therapeutics announces 1 for 40 reverse stock split
Share- Nishadil
- January 11, 2024
- 0 Comments
- 0.25 minutes read
- 14 Views
TransCode Therapeutics ( NASDAQ: RNAZ ) on Thursday announced that its Board of Directors has approved a 1 for 40 reverse stock split, to be effective on January 16, 2024. TransCode common stock is expected to begin trading on a split adjusted basis on Nasdaq under the current trading symbol, “RNAZ.” RNAZ +1.62% premarket to $0.125. Source: Press Release More on TransCode Therapeutics TransCode Therapeutics announces $1.2M registered direct offering of common stock TransCode shares plunge 20% on stock offering, Nasdaq compliance update Seeking Alpha’s Quant Rating on TransCode Therapeutics
Disclaimer: This article was generated in part using artificial intelligence and may contain errors or omissions. The content is provided for informational purposes only and does not constitute professional advice. We makes no representations or warranties regarding its accuracy, completeness, or reliability. Readers are advised to verify the information independently before relying on
